ES2045437T3 - Analogos de prostaglandinas para empleo en medicina. - Google Patents

Analogos de prostaglandinas para empleo en medicina.

Info

Publication number
ES2045437T3
ES2045437T3 ES89306121T ES89306121T ES2045437T3 ES 2045437 T3 ES2045437 T3 ES 2045437T3 ES 89306121 T ES89306121 T ES 89306121T ES 89306121 T ES89306121 T ES 89306121T ES 2045437 T3 ES2045437 T3 ES 2045437T3
Authority
ES
Spain
Prior art keywords
methyl
methylene
formula
medical use
prostaglandin analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89306121T
Other languages
English (en)
Inventor
Anjaneyulu Seetharam Tadepalli
Walker Anderson Long
James Walker Crow
Kenneth Bruce Klein
Brendan Joseph Richard Whittle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888814438A external-priority patent/GB8814438D0/en
Priority claimed from GB888824187A external-priority patent/GB8824187D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2045437T3 publication Critical patent/ES2045437T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE UN COMPUESTO DE FORMULA(I) DONDE - W - SE SELECCIONA DE LAS FORMULA(II), Y A ES 0 O 1, U ES H O HALOGENO Y Z ES - V(CH2)B - CO2H, SIENDO B UN ENTERO DE 1 A 3 Y V ES O O METILENO; X ES H, METILO, - N =, CIANO, O - C = CH; Y ES O, METILENO, - N =, O - N(AR) - DONDE AR ES UN GRUPO FENILO OPCIONALMENTE SUSTITUIDO; R ES - (CH2)5R2 DONDE R2 ES H O METILO, O R ES CICLOHEXILO, O R ES - CH(CH3)CH2C = CCH3; R1 ES H O METILO, Y LAS LINEAS PUNTEADAS SON INDEPENDIENTEMENTE ENLACES DOBLES OPCIONALE, Y SUS SALES ACEPTABLES FISIOLOGICAMENTE Y DEIVADOS ACIDOS DE ESTO, EN LA FABRICACION DE UN MEDICAMENTO PARA LA PROFILAXIS O TRATAMIENTO DE HIPERTENSION PULMONAR Y EN LA FABRICACION DE UNA AYUDA DE DIAGNOSTICO PARA IDENTIFICAR PACIENTES PPH (HIPERTENSION PULMONAR ACTIVA) CON VASOCONSTRICCION PULMONAR ACTIVA.
ES89306121T 1988-06-17 1989-06-16 Analogos de prostaglandinas para empleo en medicina. Expired - Lifetime ES2045437T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888814438A GB8814438D0 (en) 1988-06-17 1988-06-17 Compounds for use in medicine
GB888824187A GB8824187D0 (en) 1988-10-14 1988-10-14 Compounds for use in medicine

Publications (1)

Publication Number Publication Date
ES2045437T3 true ES2045437T3 (es) 1994-01-16

Family

ID=26294041

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89306121T Expired - Lifetime ES2045437T3 (es) 1988-06-17 1989-06-16 Analogos de prostaglandinas para empleo en medicina.

Country Status (12)

Country Link
EP (1) EP0347243B1 (es)
JP (1) JPH0240325A (es)
KR (1) KR0158870B1 (es)
AU (1) AU623147B2 (es)
CA (1) CA1327524C (es)
DE (1) DE68904358T2 (es)
DK (1) DK299089A (es)
ES (1) ES2045437T3 (es)
GR (1) GR3006955T3 (es)
HU (1) HU207220B (es)
MY (1) MY106300A (es)
PT (1) PT90888B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
CA2056039A1 (en) * 1991-01-22 1992-07-23 Philip L. Fuchs Carbacyclin analogs
US5190972A (en) * 1992-01-27 1993-03-02 The University Of Melbourne Method of combatting cyclosporine organ toxicity with prostaglandin analogs
KR100457499B1 (ko) * 1994-04-12 2005-02-23 도레이 가부시끼가이샤 폐성심질환치료제
EP0721783B1 (en) * 1994-06-07 2005-03-16 Toray Industries, Inc. Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung
US6046233A (en) * 1995-02-27 2000-04-04 Toray Industries, Inc. Agent for treating cor pulmonale
CN1224354A (zh) * 1997-02-27 1999-07-28 东丽株式会社 肺循环改善剂
US6521212B1 (en) * 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
EP1163333B1 (en) * 1999-03-18 2007-11-07 Queen Mary And Westfield College Inhibitors of endothelin-1 synthesis
BRPI0014869B8 (pt) 1999-10-15 2021-05-25 Sucampo Ag prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
US20090124697A1 (en) 2003-12-16 2009-05-14 United Therapeutics Corporation Inhalation formulations of treprostinil
CN1917866B (zh) 2003-12-16 2010-12-15 联合治疗公司 曲前列环素或它的衍生物，或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途
CA2678258A1 (en) * 2007-02-09 2008-08-14 United Therapeutics Corporation Treprostinil treatment for interstitial lung disease and asthma
CA2698721A1 (en) 2007-09-07 2009-03-12 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
IL252577B (en) 2014-12-03 2022-07-01 Steadymed Ltd Preservative-free treprostinil formulations and methods and devices for use with same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA787353B (en) * 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
DE3006865A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Hetero-imino-prostacycline
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
DE3315356A1 (de) * 1982-04-30 1983-11-17 Ono Pharmaceutical Co. Ltd., Osaka Verwendung von prostaglandinanalogen
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures

Also Published As

Publication number Publication date
DE68904358D1 (de) 1993-02-25
AU3652889A (en) 1989-12-21
HUT53524A (en) 1990-11-28
DE68904358T2 (de) 1993-07-29
PT90888B (pt) 1994-12-30
CA1327524C (en) 1994-03-08
PT90888A (pt) 1989-12-29
JPH0240325A (ja) 1990-02-09
KR0158870B1 (ko) 1998-12-01
AU623147B2 (en) 1992-05-07
EP0347243A1 (en) 1989-12-20
DK299089D0 (da) 1989-06-16
EP0347243B1 (en) 1993-01-13
DK299089A (da) 1989-12-18
HU207220B (en) 1993-03-29
GR3006955T3 (es) 1993-06-30
MY106300A (en) 1995-04-29
KR910000158A (ko) 1991-01-29

Similar Documents

Publication Publication Date Title
ES2045437T3 (es) Analogos de prostaglandinas para empleo en medicina.
NO20071490L (no) Farmasoytisk aktive isoindolderivater
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
ATE464292T1 (de) Pharmazeutisch aktive sulfonamid-derivate
EA199800794A1 (ru) Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения
EA200400762A1 (ru) Новые соединения, их использование в медицине, способ их изготовления и содержащие их фармацевтические композиции
SE8900192D0 (sv) Dideoxididehydrokarbocykliska nukleosider
EA200000360A1 (ru) Оральные композиции левосимендана
ES8801312A1 (es) Un procedimiento para preparar derivados de alanil-prolina.
ATE331713T1 (de) Verfahren zur herstellung von 5-nitrobenzofuranen
PA8426801A1 (es) Composiciones farmaceuticas para el tratamiento de la rinitis.
ES2142030T3 (es) Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PE20040698A1 (es) Derivados de isoindolina
IT1205729B (it) Derivati di diidrobenzofurano-e cromano-carbossammidi,procedimento per prepararli e loro impiego come neurolettici
ES2067044T3 (es) Acil-enzimas activados por la luz.
RU93044225A (ru) Новые производные метиленбисфосфоновой кислоты, способ их получения, композиция
SE8703854D0 (sv) Prostaglandinderivat for behandling av glaukom eller okuler hypertension
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
EP1306367A4 (en) SULPHONIC ACID DERIVATIVES OF HYDROXAMIC ACIDS AND THEIR USE IN MEDICAL PRODUCTS
MX9203452A (es) Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica.
NO20051282L (no) Antitumorale analoger av lamellariner.
SE7704615L (sv) Sett att framstella nya 1,4-bensodioxanderivat
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
HUP9802096A2 (hu) Piperidino-alkanol-vegyületeket tartalmazó orális adagolású oldat formájú gyógyszerkészítmény, és eljárás előállítására
DK0541263T3 (da) 5-Piperazinylalkyl-1,5-benzothiazepinoner, der er nyttige som calciumantagonister

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 347243

Country of ref document: ES